Showing 861 - 880 results of 24,341 for search '(( 50 ((nn decrease) OR (mean decrease)) ) OR ( 100 ((ng decrease) OR (a decrease)) ))', query time: 0.94s Refine Results
  1. 861
  2. 862
  3. 863

    Phosphopeptides with predicted MAPK site that showed decreased abundance in 1NM-PP1-treated <i>mak-2<sup>Q100G</sup></i> cells. by Wilfried Jonkers (160931)

    Published 2014
    “…</p>3<p>Showed reduced expression in a <i>mak-2<sup>Q100G</sup></i> germlings treated with 1NM-PP1 (19).…”
  4. 864

    Opioid consumption data. by Wali U. Pirzada (22278071)

    Published 2025
    “…Orthopaedic Surgery patients saw a mean 45% reduction in prescription size from 462 MMEs (range: 50–7200 MMEs) to 197 MMEs (range: 25–2400 MMEs) (p < .001), while General Surgery patients experienced a mean 38% reduction from 100 MMEs (range: 25–150 MMEs) to 60 MMEs (range: 25–150 MMEs) (p < .001). …”
  5. 865

    Prescription data. by Wali U. Pirzada (22278071)

    Published 2025
    “…Orthopaedic Surgery patients saw a mean 45% reduction in prescription size from 462 MMEs (range: 50–7200 MMEs) to 197 MMEs (range: 25–2400 MMEs) (p < .001), while General Surgery patients experienced a mean 38% reduction from 100 MMEs (range: 25–150 MMEs) to 60 MMEs (range: 25–150 MMEs) (p < .001). …”
  6. 866

    Refill rate by surgical specialty. by Wali U. Pirzada (22278071)

    Published 2025
    “…Orthopaedic Surgery patients saw a mean 45% reduction in prescription size from 462 MMEs (range: 50–7200 MMEs) to 197 MMEs (range: 25–2400 MMEs) (p < .001), while General Surgery patients experienced a mean 38% reduction from 100 MMEs (range: 25–150 MMEs) to 60 MMEs (range: 25–150 MMEs) (p < .001). …”
  7. 867

    Noncontinuous data on opioid use. by Wali U. Pirzada (22278071)

    Published 2025
    “…Orthopaedic Surgery patients saw a mean 45% reduction in prescription size from 462 MMEs (range: 50–7200 MMEs) to 197 MMEs (range: 25–2400 MMEs) (p < .001), while General Surgery patients experienced a mean 38% reduction from 100 MMEs (range: 25–150 MMEs) to 60 MMEs (range: 25–150 MMEs) (p < .001). …”
  8. 868
  9. 869
  10. 870
  11. 871
  12. 872
  13. 873
  14. 874
  15. 875
  16. 876
  17. 877

    Trabectedin induced apoptosis in a dose-dependent manner as measured by the Muse™ Annexin V and Dead Cell assay. by Eda Acikgoz (816259)

    Published 2015
    “…Trabectedin was shown to induce apoptotic cell death in the cancer stem cells mainly with the increase in early apoptosis (green), cells and the apparent decreased in the percentage of live cells. Trabectedin also significantly induced the total apoptotic cells (yellow) in a dose-dependent manner. …”
  18. 878

    20E repressed ILP-mediated cell membrane translocation of HaP60 and HaP110, dephosphorylated HaP60 and HaP110, and decreased their interaction. by Yu-Qin Di (8752317)

    Published 2021
    “…Bar, 50 μm. <b>C.</b> Co-IP assay showed that 20E decreased the HaP60–HaP110 interaction and induced dephosphorylation in cells. …”
  19. 879
  20. 880